Mitsubishi UFJ Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-19,071
Closed -$2.57M – 1153
2022
Q3
$2.57M Buy
19,071
+3,000
+19% +$515K 0.01% 661
2022
Q2
$2.6M Hold
16,071
– – 0.01% 655
2022
Q1
$3.03M Buy
16,071
+1,681
+12% +$357K 0.01% 656
2021
Q4
$3.88M Buy
14,390
+1,723
+14% +$582K 0.02% 629
2021
Q3
$4.6M Buy
12,667
+761
+6% +$249K 0.02% 585
2021
Q2
$4.09M Buy
11,906
+1,179
+11% +$391K 0.02% 601
2021
Q1
$3.73M Buy
10,727
+1,121
+12% +$371K 0.02% 577
2020
Q4
$2.48M Buy
9,606
+2,186
+29% +$602K 0.02% 617
2020
Q3
$2.13M Buy
7,420
+1,272
+21% +$299K 0.02% 568
2020
Q2
$1.16M Buy
6,148
+665
+12% +$108K 0.01% 655
2020
Q1
$675K Sell
5,483
-18
-0.3% -$2.81K 0.01% 690
2019
Q4
$893K Buy
5,501
+663
+14% +$110K 0.01% 720
2019
Q3
$592K Hold
4,838
– – 0.01% 713
2019
Q2
$600K Buy
4,838
+1,080
+29% +$137K 0.01% 723
2019
Q1
$496K Hold
3,758
– – 0.01% 712
2018
Q4
$482K Buy
+3,758
New +$498K 0.01% 681

Other funds holding ONC

Mitsubishi UFJ Asset Management's ONC Position: Q4 2022 in Review

Mitsubishi UFJ Asset Management sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 19,071 shares — an estimated $2.57M sold.

Mitsubishi UFJ Asset Management first reported a position in ONC in Q4 2018 and held it in 16 quarters. The position peaked at $4.6M in Q3 2021. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • Mitsubishi UFJ Asset Management reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 19,071 BeOne Medicines Ltd shares in Q4 2022, an estimated $2.57M.
  • Mitsubishi UFJ Asset Management first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 16 quarters.
  • Mitsubishi UFJ Asset Management's BeOne Medicines Ltd position peaked at $4.6M in Q3 2021.
  • 212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2022, filed 7 Feb 2023.